Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Metastatic NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06928389
What this trial is testing

Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Akeso 536
Testing effectiveness (Phase 2)Looking for participantsNCT06706713
What this trial is testing

Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerEGFR Exon 20 Insertion Mutation
BeBetter Med Inc 200
Early research (Phase 1)WithdrawnNCT05693090
What this trial is testing

Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Kura Oncology, Inc.
Early research (Phase 1)Looking for participantsNCT07229313
What this trial is testing

KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advance Solid Tumors
Kivu Bioscience Inc. 76
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Large-scale testing (Phase 3)Active Not RecruitingNCT05840016
What this trial is testing

AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Advanced Squamous Non Small Cell Lung Cancer
Akeso 532
Not applicableStudy completedNCT02596958
What this trial is testing

Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 996
Testing effectiveness (Phase 2)Ended earlyNCT02387216
What this trial is testing

MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC

Who this might be right for
Non-Small Cell Lung CancerNSCLCAdenocarcinoma+1 more
Elevation Oncology 153
Not applicableEnrolling By InvitationNCT06883136
What this trial is testing

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

Who this might be right for
Non-Small Cell Lung Cancer
Qianfoshan Hospital 43
Testing effectiveness (Phase 2)Study completedNCT02875340
What this trial is testing

VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungAdenocarcinoma
ValiSeek Limited 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06792435
What this trial is testing

XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.

Who this might be right for
Pancreatic Adenocarcinoma MetastaticLung Cancer (NSCLC)Ovarian Cancer+4 more
Astellas Pharma Global Development, Inc. 240
Large-scale testing (Phase 3)Not Yet RecruitingNCT05990127
What this trial is testing

AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic NSCLC
Akeso 642
Testing effectiveness (Phase 2)Study completedNCT00687817
What this trial is testing

Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Peregrine Pharmaceuticals 49
Testing effectiveness (Phase 2)Study completedNCT01068587
What this trial is testing

MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507188
What this trial is testing

Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients With EGFR-mutant, Locally Advanced or Metastatic/Recurrent Non-Small Cell Lung Cancer (INSTAR Study)

Who this might be right for
Non Small Cell Lung Cancer
Yonsei University 80
Testing effectiveness (Phase 2)Study completedNCT01022671
What this trial is testing

Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Chong Kun Dang Pharmaceutical 52
Large-scale testing (Phase 3)Looking for participantsNCT06119581
What this trial is testing

First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Eli Lilly and Company 1,264
Testing effectiveness (Phase 2)WithdrawnNCT02941601
What this trial is testing

Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Locally Advanced Squamous Non-Small Cell Lung CancerMetastatic Squamous Non-Small Cell Lung Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07710612
What this trial is testing

ABSK043 Combined With Osimertinib

Who this might be right for
Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
Abbisko Therapeutics Co, Ltd 72
Testing effectiveness (Phase 2)Looking for participantsNCT07655622
What this trial is testing

Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression

Who this might be right for
Non-Small-Cell Lung Cancer
Second Affiliated Hospital of Nanchang University 45
Next Page